Insmed INSM
NASDAQ INSM
$126.31 -0.37 (-0.29%)
As of: Sep 4, 2026 · 3:59 PM EDT

Insmed (INSM) Amortization - Intangibles (2018 - 2026)

Insmed (INSM) posted quarterly Amortization - Intangibles of $2.1 million for Q1 2026, up 64.77% year-over-year from $1.3 million in Q1 2025, and up 7.43% quarter-over-quarter from $1.9 million in Q4 2025.

Analysis

Insmed (INSM) Amortization - Intangibles (2018 - 2026) Analysis & Trends

Insmed's Amortization - Intangibles history runs 9 years deep, the most recent figure standing at $2.1 million for Q1 2026.

  • In Q1 2026, Amortization - Intangibles rose 64.77% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $6.8 million (up 34.98% YoY), while the FY2025 annual figure was $6.0 million, up 18.78% from the prior year.
  • Amortization - Intangibles for Q1 2026 stood at $2.1 million, up from $1.9 million in the prior quarter.
  • The five-year high for Amortization - Intangibles was $2.1 million in Q1 2026, with the low at $1.3 million in Q1 2022.
  • The 5-year median for Amortization - Intangibles is $1.3 million (2022), against an average of $1.4 million.
  • The sharpest annual moves came in 2022 and 2026: Amortization - Intangibles retreated 0.08% in 2022, then soared 64.77% in 2026.
  • Insmed's Amortization - Intangibles stood at $1.3 million in 2022, then slipped by 0.08% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024, then soared by 53.37% to $1.9 million in 2025, then climbed by 7.43% to $2.1 million in 2026.
  • Business Quant data shows INSM's Amortization - Intangibles at $2.1 million in Q1 2026, $1.9 million in Q4 2025, and $1.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.08 Mn
Mar 31, 2026 2.08 Mn
Dec 31, 2025 1.94 Mn
Sep 30, 2025 1.54 Mn
Jun 30, 2025 1.26 Mn
Mar 31, 2025 1.26 Mn
Dec 31, 2024 1.26 Mn
Sep 30, 2024 1.26 Mn
Jun 30, 2024 1.26 Mn
Mar 31, 2024 1.26 Mn
Dec 31, 2023 1.26 Mn
Sep 30, 2023 1.26 Mn
Jun 30, 2023 1.26 Mn
Mar 31, 2023 1.26 Mn
Dec 31, 2022 1.26 Mn
Sep 30, 2022 1.26 Mn
Jun 30, 2022 1.26 Mn
Mar 31, 2022 1.26 Mn
Dec 31, 2021 1.26 Mn
Sep 30, 2021 1.26 Mn